169 related articles for article (PubMed ID: 32812439)
21. A systematic review of long non-coding RNAs with a potential role in breast cancer.
Heidari R; Akbariqomi M; Asgari Y; Ebrahimi D; Alinejad-Rokny H
Mutat Res Rev Mutat Res; 2021; 787():108375. PubMed ID: 34083033
[TBL] [Abstract][Full Text] [Related]
22. Effect of the LncRNA GAS5-MiR-23a-ATG3 Axis in Regulating Autophagy in Patients with Breast Cancer.
Gu J; Wang Y; Wang X; Zhou D; Wang X; Zhou M; He Z
Cell Physiol Biochem; 2018; 48(1):194-207. PubMed ID: 30007957
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanisms of long noncoding RNAs on gastric cancer.
Li T; Mo X; Fu L; Xiao B; Guo J
Oncotarget; 2016 Feb; 7(8):8601-12. PubMed ID: 26788991
[TBL] [Abstract][Full Text] [Related]
24. Clinical Significance of Long Non-coding RNA MALAT1 Expression in Tissue and Serum of Breast Cancer.
Miao Y; Fan R; Chen L; Qian H
Ann Clin Lab Sci; 2016 Jul; 46(4):418-24. PubMed ID: 27466303
[TBL] [Abstract][Full Text] [Related]
25. A Panel of Serum Noncoding RNAs for the Diagnosis and Monitoring of Response to Therapy in Patients with Breast Cancer.
Huang SK; Luo Q; Peng H; Li J; Zhao M; Wang J; Gu YY; Li Y; Yuan P; Zhao GH; Huang CZ
Med Sci Monit; 2018 Apr; 24():2476-2488. PubMed ID: 29683112
[TBL] [Abstract][Full Text] [Related]
26. Circulating long non-coding HOX transcript antisense intergenic ribonucleic acid in plasma as a potential biomarker for diagnosis of breast cancer.
Zhang Y; Zhang K; Luo Z; Liu L; Wu L; Liu J
Thorac Cancer; 2016 Nov; 7(6):627-632. PubMed ID: 27755794
[TBL] [Abstract][Full Text] [Related]
27. The use of Human Inflammatory Response and Autoimmunity RT2 lncRNA PCR Array for plasma examination in breast cancer patients prior to therapy.
Sterbova M; Pazourkova E; Santorova-Pospisilova S; Zednikova I; Tesarova P; Korabecna M
Neoplasma; 2019 Jul; 66(4):641-646. PubMed ID: 30943749
[TBL] [Abstract][Full Text] [Related]
28. Large intergenic non-coding RNA-ROR as a potential biomarker for the diagnosis and dynamic monitoring of breast cancer.
Zhao T; Wu L; Li X; Dai H; Zhang Z
Cancer Biomark; 2017 Aug; 20(2):165-173. PubMed ID: 28869448
[TBL] [Abstract][Full Text] [Related]
29. Cell-free lncRNA expression signatures in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
Du L; Duan W; Jiang X; Zhao L; Li J; Wang R; Yan S; Xie Y; Yan K; Wang Q; Wang L; Yang Y; Wang C
J Cell Mol Med; 2018 May; 22(5):2838-2845. PubMed ID: 29516641
[TBL] [Abstract][Full Text] [Related]
30. Roles and Mechanisms of the Long Noncoding RNAs in Cervical Cancer.
Cáceres-Durán MÁ; Ribeiro-Dos-Santos Â; Vidal AF
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371204
[TBL] [Abstract][Full Text] [Related]
31. Long Noncoding RNA GAS5 in Breast Cancer: Epigenetic Mechanisms and Biological Functions.
Filippova EA; Fridman MV; Burdennyy AM; Loginov VI; Pronina IV; Lukina SS; Dmitriev AA; Braga EA
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202777
[TBL] [Abstract][Full Text] [Related]
32. Aberrant expression of long noncoding RNA SNHG15 correlates with liver metastasis and poor survival in colorectal cancer.
Huang L; Lin H; Kang L; Huang P; Huang J; Cai J; Xian Z; Zhu P; Huang M; Wang L; Xian CJ; Wang J; Dong J
J Cell Physiol; 2019 May; 234(5):7032-7039. PubMed ID: 30317592
[TBL] [Abstract][Full Text] [Related]
33. Identification of a stool long non-coding RNAs panel as a potential biomarker for early detection of colorectal cancer.
Gharib E; Nazemalhosseini-Mojarad E; Baghdar K; Nayeri Z; Sadeghi H; Rezasoltani S; Jamshidi-Fard A; Larki P; Sadeghi A; Hashemi M; Asadzadeh Aghdaei H
J Clin Lab Anal; 2021 Feb; 35(2):e23601. PubMed ID: 33094859
[TBL] [Abstract][Full Text] [Related]
34. Serum HOTAIR and GAS5 levels as predictors of survival in patients with glioblastoma.
Shen J; Hodges TR; Song R; Gong Y; Calin GA; Heimberger AB; Zhao H
Mol Carcinog; 2018 Jan; 57(1):137-141. PubMed ID: 28926136
[TBL] [Abstract][Full Text] [Related]
35. Serum long non-coding RNAs MALAT1, AFAP1-AS1 and AL359062 as diagnostic and prognostic biomarkers for nasopharyngeal carcinoma.
He B; Zeng J; Chao W; Chen X; Huang Y; Deng K; Huang Z; Li J; Dai M; Chen S; Huang H; Dai S
Oncotarget; 2017 Jun; 8(25):41166-41177. PubMed ID: 28467811
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA chromogenic in situ hybridisation signal pattern correlation with breast tumour pathology.
Zhang Z; Weaver DL; Olsen D; deKay J; Peng Z; Ashikaga T; Evans MF
J Clin Pathol; 2016 Jan; 69(1):76-81. PubMed ID: 26323944
[TBL] [Abstract][Full Text] [Related]
37. Interplay of lncRNA H19/miR-675 and lncRNA NEAT1/miR-204 in breast cancer.
Müller V; Oliveira-Ferrer L; Steinbach B; Pantel K; Schwarzenbach H
Mol Oncol; 2019 May; 13(5):1137-1149. PubMed ID: 30803129
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNAs MALAT1, MIAT and ANRIL gene expression profiles in beta-thalassemia patients: a cross-sectional analysis.
Fakhr-Eldeen A; Toraih EA; Fawzy MS
Hematology; 2019 Dec; 24(1):308-317. PubMed ID: 30665334
[TBL] [Abstract][Full Text] [Related]
39. The expression of lncRNA-MALAT1 in breast cancer patients and its influences on prognosis.
Sun Z; Liu J; Liu J
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):72-78. PubMed ID: 32538750
[TBL] [Abstract][Full Text] [Related]
40. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.
Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C
Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
